Report Overview
Peripheral drug-eluting balloons (DEBs) are medical devices used in the treatment of peripheral artery disease (PAD). These balloons are coated with an anti-proliferative drug that is released into the artery during angioplasty, helping to prevent restenosis by inhibiting the growth of scar tissue. Peripheral DEBs are designed to deliver targeted therapy to the site of the arterial lesion, offering a minimally invasive treatment option for patients with PAD. This technology represents a significant advancement in the field of interventional cardiology, providing an alternative to traditional balloon angioplasty and stenting procedures.
The market for peripheral drug-eluting balloons is experiencing steady growth driven by several key factors. One of the primary market drivers is the increasing prevalence of PAD globally, particularly among the aging population. As the incidence of risk factors such as diabetes, obesity, and smoking continues to rise, the demand for effective treatment options for PAD is also increasing. Peripheral DEBs offer a less invasive and more cost-effective alternative to traditional revascularization procedures, making them an attractive option for both patients and healthcare providers. Additionally, advancements in balloon coating technologies and the development of new drug formulations are further driving market growth by improving the efficacy and safety profile of these devices.
In addition to the growing prevalence of PAD and technological advancements, the market for peripheral drug-eluting balloons is also influenced by factors such as increasing healthcare expenditure, rising awareness about minimally invasive treatment options, and expanding reimbursement policies. These factors are expected to contribute to the continued expansion of the market in the coming years. However, challenges such as the high cost of DEB procedures, limited availability of specialized healthcare facilities, and regulatory hurdles in some regions may hinder market growth to some extent. Overall, the market for peripheral drug-eluting balloons is poised for significant growth as the demand for minimally invasive treatment options for PAD continues to rise.
The global Peripheral Drug-eluting Balloon market size was estimated at USD 609.80 million in 2024 and is projected to reach USD 1446.34 million by 2033, exhibiting a CAGR of 11.40% during the forecast period.
This report provides a deep insight into the global Peripheral Drug-eluting Balloon market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, PEST analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peripheral Drug-eluting Balloon Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peripheral Drug-eluting Balloon market in any manner.
Global Peripheral Drug-eluting Balloon Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Medtronic
Boston Scientific
Terumo Corporation
Acotec
BD
Surmodics
Biotronik
Shanghai MicroPort Endovascular MedTech（Group）Co.
Ltd.
Zylox-Tonbridge Medical Technology Co.
Ltd.
Market Segmentation (by Type)
Paclitaxel
Others
Market Segmentation (by Application)
Lower Limbs
Renal Artery
Carotid Artery
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Peripheral Drug-eluting Balloon Market
• Overview of the regional outlook of the Peripheral Drug-eluting Balloon Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Drug-eluting Balloon Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market’s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter’s five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Peripheral Drug-eluting Balloon, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.